Mortality rates for pulmonary embolism differ significantly, indicating a need for escalated management. Treatment options include systemic anticoagulation, catheter-directed thrombolysis and/or thrombectomy and surgical thrombectomy. Heparin-induced thrombocytopenia is a severe complication as a result of any form of heparin which limits pharmacologic therapy with thrombolytics and anticoagulation.